News

Article

PharmTech Sponsored eBooks

PharmTech Sponsored eBooks

PharmTech Sponsored eBooks-05-01-2020
VolumeSponsored eBook
Issue 6
Pages: 44–45,58

Minimizing Contamination During BioPharm R&D

Author(s):

David Phillips

The right approach to biological safety cabinets, and collaboration between engineers and those who will operate the equipment, is crucial to preventing cell-culture contamination.

Cell-culture contamination is a common challenge facing cell-culture laboratories, with consequences that range from minor to devastating. Every effort must be made to protect the integrity of cell cultures, both for the experiments that are being performed in the laboratory, as well as to prevent problems later on, downstream. When selected and designed correctly, biological safety cabinets (BSCs) play a critical role in protecting cell cultures, laboratory personnel, and the environment. 

Read this article in Pharmaceutical Technology eBook: Biologics and Sterile Drug Manufacturing, May 2020, Pages: 34–37

Article Details 

Pharmaceutical Technology eBook: Biologics and Sterile Drug Manufacturing
May 2020
Pages: 34–37

Citation 

When referring to this article, please cite it as author, “Minimizing Contamination During Biopharma R&D," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2020).

 

 

Articles in this issue
Screen Shot 2020-06-01 at 9.32.11 AM.png
Complications in Process Simulation Execution
Screen Shot 2020-06-01 at 10.46.20 AM.png
Minimizing Contamination During BioPharm R&D
Trends and Formulation Strategies for Topical Drugs

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content
automatic stainless steel pharmaceutical fermenter | Image Credit: ©gen_A - stock.adobe.com
August 1st 2025

In-line UV Spectrometry Monitoring in Cleaning Validation

John Schallom Brian Bosso Paul Lopolito Katie Frey Amy Thanavaro
The authors performed interference and enhancement testing using a formulated alkaline and acid cleaner, as well as common biopharmaceutical process residues.
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 1st 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.
woman face and hand with syringe making injection | Image Credit: © Syda Productions - stock.adobe.com
August 1st 2025

Boehringer Ingelheim, Re-Vana Therapeutics to Collaborate on Long-Acting Ophthalmic Therapies

Patrick Lavery
Re-Vana’s drug delivery technology is designed to release treatments over a 6- to 12-month period, with the goal of reducing frequency of injections for patients.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 1st 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
medicine factory scientist worker work in Laboratory Plants Process. medical doctor working research in pharmaceutical industry. | Image Credit: ©Quality Stock Arts – stock.adobe.com
August 1st 2025

Interfering with Interventions in Aseptic Processing

James Agalloco
Addressing human interventions to reduce their impact on contamination requires addressing broader considerations than limiting operator activities. Equipment, automation, procedural and component changes can be utilized to make the aseptic activities safer. This article offers suggestions for reducing the adverse impact of intervention throughout the aseptic process.
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 1st 2025

EMA Approves Lower GWP Alternative for Inhalation Medicine

Susan Haigney
The agency has given a positive recommendation for a change in the gas propellant in Trixeo Aerosphere and Riltrava Aerosphere that will have a 1000-fold reduction in global warming potential compared to the current propellant.